Diagnosis and challenges of polycystic ovary syndrome in adolescence

Seminars in Reproductive Medicine

Volumn 32, Issue 3, 2014, Pages 194-201

  Agapova, Sophia E ^a   Cameo, Tamara ^a   Sopher, Aviva B ^a   Oberfield, Sharon E ^a  

^a Department of Medicine   (United States)

Author keywords

polycystic ovarian morphology; polycystic ovary syndrome; type 2 diabetes mellitus

Indexed keywords

ACNE; ADOLESCENT DISEASE; ALOPECIA; ANOVULATION; ARTICLE; ECHOGRAPHY; HIRSUTISM; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; MENSTRUAL IRREGULARITY; METABOLIC SYNDROME X; OBESITY; OVARY; OVARY POLYCYSTIC DISEASE; ADOLESCENT; AGE; FEMALE; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYCYSTIC OVARY SYNDROME;

ADOLESCENT; AGE FACTORS; FEMALE; HIRSUTISM; HUMANS; HYPERANDROGENISM; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME;

EID: 84898435675     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0034-1371091     Document Type: Article

References (111)

1. Zawadski J. K., Dunaif A. Diagnostic criteria for polycystic ovary syndrome; towards a rational approach. In: Dunaif A., Givens J. R., Haseltine F., eds. Polycystic Ovary Syndrome. Boston, MA Blackwell Scientific: 1992; 377 384
2. Franks S. Polycystic ovary syndrome. N Engl J Med: 1995; 333 13 853 861
3. National Institutes of Health Evidence-Based Methodology Workshop on Polycystic Ovary Syndrome: Executive Summary. Washington National Institutes of Health: 2012
4. Roe A. H., Dokras A. The diagnosis of polycystic ovary syndrome in adolescents. Rev Obstet Gynecol: 2011; 4 2 45 51
5. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod: 2004; 19 1 1 7
6. Azziz R., Carmina E., Dewailly D., et al. Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab: 2006; 91 11 4237 4245 (Pubitemid 44833391)
7. Ben Salem Hachmi L., Ben Salem Hachmi S., Bouzid C., et al. Hypertension in polycystic ovary syndrome [in French]. Arch Mal Coeur Vaiss: 2006; 99 7-8 687 690 (Pubitemid 46211662)
8. Hoppin A. G., Katz E. S., Kaplan L. M., Lauwers G. Y. Case records of the Massachusetts General Hospital. Case 31-2006. A 15-year-old girl with severe obesity. N Engl J Med: 2006; 355 15 1593 1602 (Pubitemid 44547811)
9. Mortensen M., Rosenfield R. L., Littlejohn E. Functional significance of polycystic-size ovaries in healthy adolescents. J Clin Endocrinol Metab: 2006; 91 10 3786 3790 (Pubitemid 44536844)
10. Harris Y. S., McDonald S. B. An African American female with irregular menses and weight gain. Pediatr Nurs: 2006; 32 4 354 357
11. De Leo V., Musacchio M. C., Morgante G., Piomboni P., Petraglia F. Metformin treatment is effective in obese teenage girls with PCOS. Hum Reprod: 2006; 21 9 2252 2256 (Pubitemid 44530597)
12. Glueck C. J., Aregawi D., Winiarska M., et al. Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab: 2006; 19 6 831 842 (Pubitemid 44083540)
13. Glueck C. J., Morrison J. A., Friedman L. A., Goldenberg N., Stroop D. M., Wang P. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents. Metabolism: 2006; 55 4 508 514
14. Fulghesu A. M., Angioni S., Portoghese E., et al. Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome. Fertil Steril: 2006; 86 2 398 404 (Pubitemid 44118963)
15. Nicoletti A. Paradigm shift. J Pediatr Adolesc Gynecol: 2006; 19 4 317 318 (Pubitemid 44093307)
16. Vambergue A., Lautier C., Valat A. S., Cortet-Rudelli C., Grigorescu F., Dewailly D. Follow-up study of two sisters with type A syndrome of severe insulin resistance gives a new insight into PCOS pathogenesis in relation to puberty and pregnancy outcome: a case report. Hum Reprod: 2006; 21 5 1274 1278
17. Leibel N. I., Baumann E. E., Kocherginsky M., Rosenfield R. L. Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome. J Clin Endocrinol Metab: 2006; 91 4 1275 1283
18. Mastorakos G., Koliopoulos C., Deligeoroglou E., Diamanti-Kandarakis E., Creatsas G. Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome. Fertil Steril: 2006; 85 2 420 427 (Pubitemid 43170917)
19. Yoo R. Y., Dewan A., Basu R., Newfield R., Gottschalk M., Chang R. J. Increased luteinizing hormone pulse frequency in obese oligomenorrheic girls with no evidence of hyperandrogenism. Fertil Steril: 2006; 85 4 1049 1056
20. Bridger T., MacDonald S., Baltzer F., Rodd C. Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome. Arch Pediatr Adolesc Med: 2006; 160 3 241 246 (Pubitemid 43374356)
21. Coviello A. D., Legro R. S., Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab: 2006; 91 2 492 497 (Pubitemid 43236914)
22. Triantafyllopoulou M., Whitington P. F., Melin-Aldana H., Benya E. C., Brickman W. Hepatic adenoma in an adolescent with elevated androgen levels. J Pediatr Gastroenterol Nutr: 2007; 44 5 640 642 (Pubitemid 46684370)
23. Demirel F., Bideci A., Cinaz P., et al. Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome. Clin Endocrinol (Oxf): 2007; 67 1 129 134 (Pubitemid 46955452)
24. Sun L., Fu Q. Three-dimensional transrectal ultrasonography in adolescent patients with polycystic ovarian syndrome. Int J Gynaecol Obstet: 2007; 98 1 34 38 (Pubitemid 46898392)
25. Luque-Ramírez M., Alvarez-Blasco F., Mendieta-Azcona C., Botella-Carretero J. I., Escobar-Morreale H. F. Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome. J Clin Endocrinol Metab: 2007; 92 6 2141 2148 (Pubitemid 46997113)
26. Nazari T., Bayat R., Hamedi M. Metformin therapy in girls with polycystic ovary syndrome: a self-controlled clinical trial. Arch Iran Med: 2007; 10 2 176 181 (Pubitemid 46672408)
27. Littlejohn E. E., Weiss R. E., Deplewski D., Edidin D. V., Rosenfield R. Intractable early childhood obesity as the initial sign of insulin resistant hyperinsulinism and precursor of polycystic ovary syndrome. J Pediatr Endocrinol Metab: 2007; 20 1 41 51 (Pubitemid 46863537)
28. Sharquie K. E., Al-Bayatti A. A., Al-Ajeel A. I., Al-Bahar A. J., Al-Nuaimy A. A. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome. Saudi Med J: 2007; 28 7 1039 1043
29. Chen M. J., Yang W. S., Yang J. H., Chen C. L., Ho H. N., Yang Y. S. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome. Hypertension: 2007; 49 6 1442 1447
30. Rachmiel M., Kives S., Atenafu E., Hamilton J. Primary amenorrhea as a manifestation of polycystic ovarian syndrome in adolescents: a unique subgroup? Arch Pediatr Adolesc Med: 2008; 162 6 521 525 (Pubitemid 351786951)
31. Bhattacharya S. M. Metabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria. J Obstet Gynaecol Res: 2008; 34 1 62 66 (Pubitemid 351143719)
32. Ibáñez L., López-Bermejo A., Callejo J., et al. Polycystic ovaries in nonobese adolescents and young women with ovarian androgen excess: relation to prenatal growth. J Clin Endocrinol Metab: 2008; 93 1 196 199
33. Valdés P., Cerda A., Barrenechea C., Kehr M., Soto C., Salazar L. A. No association between common Gly972Arg variant of the insulin receptor substrate-1 and polycystic ovary syndrome in Southern Chilean women. Clin Chim Acta: 2008; 390 1-2 63 66
34. Rossi B., Sukalich S., Droz J., et al. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome. J Clin Endocrinol Metab: 2008; 93 12 4780 4786
35. Fruzzetti F., Perini D., Lazzarini V., Parrini D., Genazzani A. R. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril: 2009; 92 2 626 634
36. Hart R., Doherty D. A., Norman R. J., et al. Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertil Steril: 2010; 94 3 1118 1121
37. Huang J., Ni R., Chen X., Huang L., Mo Y., Yang D. Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China. Reprod Biol Endocrinol: 2010; 8 142
38. Shah B., Parnell L., Milla S., Kessler M., David R. Endometrial thickness, uterine, and ovarian ultrasonographic features in adolescents with polycystic ovarian syndrome. J Pediatr Adolesc Gynecol: 2010; 23 3 146 152
39. Li L., Chen X., Mo Y., Chen Y., Wenig M., Yang D. Elevated serum anti-mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome. Wien Klin Wochenschr: 2010; 122 17-18 519 524
40. Bekx M. T., Connor E. C., Allen D. B. Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome. J Pediatr Adolesc Gynecol: 2010; 23 1 7 10
41. Bhattacharya S. M., Jha A. Prevalence and risk of metabolic syndrome in adolescent Indian girls with polycystic ovary syndrome using the 2009 'joint interim criteria'. J Obstet Gynaecol Res: 2011; 37 10 1303 1307
42. Bronstein J., Tawdekar S., Liu Y., Pawelczak M., David R., Shah B. Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought. J Pediatr Adolesc Gynecol: 2011; 24 1 15 20
43. Hart R., Doherty D. A., Mori T., et al. Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome. Fertil Steril: 2011; 95 7 2347 2353, e1
44. Hickey M., Doherty D. A., Atkinson H., et al. Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. Hum Reprod: 2011; 26 6 1469 1477
45. Morrison J. A., Glueck C. J., Daniels S., Wang P., Stroop D. Adolescent oligomenorrhea in a biracial schoolgirl cohort: a simple clinical parameter predicting impaired fasting glucose plus type 2 diabetes mellitus, insulin, glucose, insulin resistance, and centripetal obesity from age 19 to 25 years. Metabolism: 2011; 60 9 1285 1293
46. Nidhi R., Padmalatha V., Nagarathna R., Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol: 2011; 24 4 223 227
47. Codner E., Villarroel C., Eyzaguirre F. C., et al. Polycystic ovarian morphology in postmenarchal adolescents. Fertil Steril: 2011; 95 2 702 706, e1-e2
48. Jones G. L., Hall J. M., Lashen H. L., Balen A. H., Ledger W. L. Health-related quality of life among adolescents with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs: 2011; 40 5 577 588
49. Ladson G., Dodson W. C., Sweet S. D., et al. The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study. Fertil Steril: 2011; 95 3 1059 1066, e1-e7
50. Forrester-Dumont K., Galescu O., Kolesnikov A., et al. Hyperandrogenism does not influence metabolic parameters in adolescent girls with PCOS. Int J Endocrinol: 2012; 2012 434830
51. Nair M. K., Pappachan P., Balakrishnan S., Leena M. L., George B., Russell P. S. Menstrual irregularity and poly cystic ovarian syndrome among adolescent girls-a 2year follow-up study. Indian J Pediatr: 2012; 79 01 S69 S73
52. Rahmanpour H., Jamal L., Mousavinasab S. N., Esmailzadeh A., Azarkhish K. Association between polycystic ovarian syndrome, overweight, and metabolic syndrome in adolescents. J Pediatr Adolesc Gynecol: 2012; 25 3 208 212
53. Villa P., Rossodivita A., Sagnella F., et al. Ovarian volume and gluco-insulinaemic markers in the diagnosis of PCOS during adolescence. Clin Endocrinol (Oxf): 2013; 78 2 285 290
54. Pinola P., Lashen H., Bloigu A., et al. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study. Hum Reprod: 2012; 27 11 3279 3286
55. Brown M., Park A. S., Shayya R. F., Wolfson T., Su H. I., Chang R. J. Ovarian imaging by magnetic resonance in adolescent girls with polycystic ovary syndrome and age-matched controls. J Magn Reson Imaging: 2013; 38 3 689 693
56. Li L., Chen X., He Z., Zhao X., Huang L., Yang D. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents. J Pediatr Adolesc Gynecol: 2012; 25 6 390 395
57. Geier L. M., Bekx M. T., Connor E. L. Factors contributing to initial weight loss among adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol: 2012; 25 6 367 370
58. Jakubowski K. P., Black J. J., El Nokali N. E., et al. Parents' readiness to change affects BMI reduction outcomes in adolescents with polycystic ovary syndrome. J Obes: 2012; 2012 298067
59. Nandalike K., Agarwal C., Strauss T., et al. Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome. Sleep Med: 2012; 13 10 1307 1312
60. Nidhi R., Padmalatha V., Nagarathna R., Amritanshu R. Effect of holistic yoga program on anxiety symptoms in adolescent girls with polycystic ovarian syndrome: A randomized control trial. Int J Yoga: 2012; 5 2 112 117
61. To W. W., Wong M. W. A comparison of bone mineral density in normal weight and obese adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol: 2012; 25 4 248 253
62. Nidhi R., Padmalatha V., Nagarathna R., Ram A. Effect of a yoga program on glucose metabolism and blood lipid levels in adolescent girls with polycystic ovary syndrome. Int J Gynaecol Obstet: 2012; 118 1 37 41
63. Ganie M. A., Farooqui K. J., Bhat M. A., et al. Pattern of urinary albumin excretion in normotensive young and adolescent Indian women with polycystic ovary syndrome. Indian J Endocrinol Metab: 2012; 16 2 277 282
64. Sopher A. B., Gerken A. T., Blaner W. S., Root J. M., McMahon D. J., Oberfield S. E. Metabolic manifestations of polycystic ovary syndrome in nonobese adolescents: retinol-binding protein 4 and ectopic fat deposition. Fertil Steril: 2012; 97 4 1009 1015
65. Deveer R., Engin-Üstün Y., Uysal S., et al. Serum brain natriuretic peptide and C-reactive protein levels in adolescent with polycystic ovary syndrome. Gynecol Endocrinol: 2012; 28 8 602 605
66. Eleftheriadou M., Michala L., Stefanidis K., Iliadis I., Lykeridou A., Antsaklis A. Exercise and sedentary habits among adolescents with PCOS. J Pediatr Adolesc Gynecol: 2012; 25 3 172 174
67. Bechtold S., Dalla Pozza R., Putzker S., et al. Effect of antiandrogen treatment on bone density and bone geometry in adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol: 2012; 25 3 175 180
68. de Sousa G., Schlüter B., Menke T., Trowitzsch E., Andler W., Reinehr T. Longitudinal analyses of polysomnographic variables, serum androgens, and parameters of glucose metabolism in obese adolescents with polycystic ovarian syndrome. Sleep Breath: 2012; 16 4 1139 1146
69. Pawelczak M., Kenigsberg L., Milla S., Liu Y. H., Shah B. Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features. J Pediatr Endocrinol Metab: 2012; 25 9-10 983 989
70. Roe A. H., Prochaska E., Smith M., Sammel M., Dokras A. Using the androgen excess-PCOS society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents. J Pediatr: 2013; 162 5 937 941
71. Milsom S. R., Nair S. M., Ogilvie C. M., Stewart J. M., Merry S. N. Polycystic ovary syndrome and depression in New Zealand adolescents. J Pediatr Adolesc Gynecol: 2013; 26 3 142 147
72. Auble B., Elder D., Gross A., Hillman J. B. Differences in the management of adolescents with polycystic ovary syndrome across pediatric specialties. J Pediatr Adolesc Gynecol: 2013; 26 4 234 238
73. Zachurzok A., Deja G., Gawlik A., Drosdzol-Cop A., Małecka-Tendera E. Hyperandrogenism in adolescent girls with type 1 diabetes mellitus treated with intensive and continuous subcutaneous insulin therapy. Endokrynol Pol: 2013; 64 2 121 128
74. Jeon Y. E., Lee K. E., Jung J. A., et al. Kisspeptin, leptin, and retinol-binding protein 4 in women with polycystic ovary syndrome. Gynecol Obstet Invest: 2013; 75 4 268 274
75. Christensen S. B., Black M. H., Smith N., et al. Prevalence of polycystic ovary syndrome in adolescents. Fertil Steril: 2013; 100 2 470 477
76. Kale-Gurbuz T., Akhan S. E., Bastu E., Telci A., Iyibozkurt A. C., Topuz S. Adiponectin, leptin and ghrelin levels in obese adolescent girls with polycystic ovary syndrome. J Pediatr Adolesc Gynecol: 2013; 26 1 27 30
77. Bredella M. A., McManus S., Misra M. Impact of metformin monotherapy versus metformin with oestrogen-progesterone on lipids in adolescent girls with polycystic ovarian syndrome. Clin Endocrinol (Oxf): 2013; 79 2 199 203
78. Yin Q., Chen X., Li L., Zhou R., Huang J., Yang D. Apolipoprotein B/apolipoprotein A1 ratio is a good predictive marker of metabolic syndrome and pre-metabolic syndrome in Chinese adolescent women with polycystic ovary syndrome. J Obstet Gynaecol Res: 2013; 39 1 203 209
79. Flannery C. A., Rackow B., Cong X., Duran E., Selen D. J., Burgert T. S. Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI. Pediatr Diabetes: 2013; 14 1 42 49
80. Carmina E., Oberfield S. E., Lobo R. A. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol: 2010; 203 3 e1 e5
81. Hardy T. S., Norman R. J. Diagnosis of adolescent polycystic ovary syndrome. Steroids: 2013; 78 8 751 754
82. Sultan C., Paris F. Clinical expression of polycystic ovary syndrome in adolescent girls. Fertil Steril: 2006; 86 01 S6 (Pubitemid 43949267)
83. Fauser B. C., Tarlatzis B. C., Rebar R. W., et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril: 2012; 97 01 28.e25 38.e25
84. Rosner W., Auchus R. J., Azziz R., Sluss P. M., Raff H. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab: 2007; 92 2 405 413
85. Biro F. M., Emans S. J. Whither PCOS? The challenges of establishing hyperandrogenism in adolescent girls. J Adolesc Health: 2008; 43 2 103 105 (Pubitemid 351970703)
86. Yildiz B. O., Bolour S., Woods K., Moore A., Azziz R. Visually scoring hirsutism. Hum Reprod Update: 2010; 16 1 51 64
87. Martin K. A., Chang R. J., Ehrmann D. A., et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab: 2008; 93 4 1105 1120 (Pubitemid 351519694)
88. Merino P. M., Codner E., Cassorla F. A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence. Arq Bras Endocrinol Metabol: 2011; 55 8 590 598
89. Legro R. S., Schlaff W. D., Diamond M. P., et al. Reproductive Medicine Network. Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab: 2010; 95 12 5305 5313
90. Janse F., Eijkemans M. J., Goverde A. J., et al. Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results. Eur J Endocrinol: 2011; 165 6 925 933
91. Haring R., Hannemann A., John U., et al. Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab: 2012; 97 2 408 415
92. Kushnir M. M., Blamires T., Rockwood A. L., et al. Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals. Clin Chem: 2010; 56 7 1138 1147
93. Fanelli F., Gambineri A., Belluomo I., et al. Androgen profiling by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in healthy normal-weight ovulatory and anovulatory late adolescent and young women. J Clin Endocrinol Metab: 2013; 98 7 3058 3067
94. Apter D., Vihko R. Serum pregnenolone, progesterone, 17- hydroxyprogesterone, testosterone and 5 alpha-dihydrotestosterone during female puberty. J Clin Endocrinol Metab: 1977; 45 5 1039 1048 (Pubitemid 8238620)
95. van Hooff M. H., Voorhorst F. J., Kaptein M. B., Hirasing R. A., Koppenaal C., Schoemaker J. Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years. Hum Reprod: 2004; 19 2 383 392 (Pubitemid 38220012)
96. Rosenfield R. L. Clinical review: Adolescent anovulation: maturational mechanisms and implications. J Clin Endocrinol Metab: 2013; 98 9 3572 3583
97. Jeffrey Chang R., Coffler M. S. Polycystic ovary syndrome: early detection in the adolescent. Clin Obstet Gynecol: 2007; 50 1 178 187 (Pubitemid 46279861)
98. Hassan A., Gordon C. M. Polycystic ovary syndrome update in adolescence. Curr Opin Pediatr: 2007; 19 4 389 397 (Pubitemid 47075618)
99. Dewailly D., Gronier H., Poncelet E., et al. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Human Reprod: 2001; 26 11 3123 3129
100. Johnstone E. B., Rosen M. P., Neril R., et al. The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance. J Clin Endocrinol Metab: 2010; 95 11 4965 4972
101. Villarroel C., Merino P. M., López P., et al. Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone. Hum Reprod: 2011; 26 10 2861 2868
102. Williams R. M., Ong K. K., Dunger D. B. Polycystic ovarian syndrome during puberty and adolescence. Mol Cell Endocrinol: 2013; 373 1-2 61 67
103. Chen Y., Yang D., Li L., Chen X. The role of ovarian volume as a diagnostic criterion for Chinese adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol: 2008; 21 6 347 350
104. Yoo R. Y., Sirlin C. B., Gottschalk M., Chang R. J. Ovarian imaging by magnetic resonance in obese adolescent girls with polycystic ovary syndrome: a pilot study. Fertil Steril: 2005; 84 4 985 995 (Pubitemid 41414590)
105. Eilertsen T. B., Vanky E., Carlsen S. M. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod: 2012; 27 8 2494 2502
106. Huang G., Coviello A. Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome. Curr Opin Endocrinol Diabetes Obes: 2012; 19 6 512 519
107. Hoeger K. M., Oberfield S. E. Do women with PCOS have a unique predisposition to obesity? Fertil Steril: 2012; 97 1 13 17
108. Nicandri K. F., Hoeger K. Diagnosis and treatment of polycystic ovarian syndrome in adolescents. Curr Opin Endocrinol Diabetes Obes: 2012; 19 6 497 504
109. Glueck C. J., Morrison J. A., Daniels S., Wang P., Stroop D. Sex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years. J Pediatr: 2011; 159 2 308 313, e2
110. Salley K. E., Wickham E. P., Cheang K. I., Essah P. A., Karjane N. W., Nestler J. E. Glucose intolerance in polycystic ovary syndrome-a position statement of the Androgen Excess Society. J Clin Endocrinol Metab: 2007; 92 12 4546 4556 (Pubitemid 350223423)
111. Palmert M. R., Gordon C. M., Kartashov A. I., Legro R. S., Emans S. J., Dunaif A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab: 2002; 87 3 1017 1023 (Pubitemid 36121058)